High Rate of Virological Response to Peginterferon α-2a–Ribavirin Among Non-Cirrhotic Iranian Hemophilia Patients With Chronic Hepatitis C

BACKGROUND: Hepatitis C is a major reason of morbidity and mortality among hemophilia patients. Although combination therapy with peginterferon (peg-INF) and ribavirin is considered as standard treatment for chronic hepatitis C (CHC), but more evidence of the efficacy and safety is needed. OBJECTIVE...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Alavi Moghaddam, Mostafa, Zali, Mohammad Reza, Aalaei Andabili, Seyed Hossein, Derakhshan, Faramarz, Miri, Seyed Mohammad, Alavian, Seyed Moayed
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Kowsar 2012
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3470839/
https://ncbi.nlm.nih.gov/pubmed/23105981
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items